Cover Image
Market Research Report

Philippines Pharmaceuticals & Healthcare Q2 2020

Published by Fitch Solutions, Inc. Product code 177615
Published Content info 62 Pages
Delivery time: 1-2 business days
Back to Top
Philippines Pharmaceuticals & Healthcare Q2 2020
Published: March 3, 2020 Content info: 62 Pages

Key View:

If the maximum retail price scheme is implemented in the Philippines, which President Rodrigo Duterte has assured

citizens will happen, there will be a sizeable downward revision to the country's pharmaceutical market forecast. The proposed

policy adopts practices implemented elsewhere and follows existing legislation designed to widen access to medicines in the

Philippines. It is possible that the scheme may not deliver the intended benefits and could hinder the introduction of future

pharmaceutical innovations. Though, looking at a long term, MRP should encourage higher volume sales and greater competition in

the market, which would make these planned price controls a positive for the market.

Table of Contents
Product Code: SSPH03_20200401

Table of Contents

  • Key View
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast
  • Industry Risk/Reward Index
  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Innovative Pharmaceuticals Risk/Reward Index
  • Regulatory Development
  • Regulatory Review
  • Market Overview

Competitive Landscape

  • Company Profile
  • GlaxoSmithKline
  • Novartis
  • Philippines Demographic Outlook
  • Pharmaceuticals & Healthcare Glossary
  • Pharmaceuticals & Healthcare Methodology
Back to Top